Pharmacyte Biotech (PMCB)'s 30-day implied volatility (IV30) was 121.2% at the close on November 9, 2026, down from 140.9% the day before, against a 52-week range of 61.1% to 308.8%. Its 20-day historical volatility was 169.7%.
Data as of November 9, 2026.